Clinical studies have shown that people using Mounjaro for weight management have seen significant reductions in body weight
With Ozempic/Wegovy, average weight loss is 15-20% of body weight over 68 weeks, with some people losing more and others less
On top of the medication, a few other factors can contribute to constipation on a GLP-1: Eating less overall Less food bulk moving through your system Lower fiber intake Portion sizes may shrink, which can lead to fewer nutrients your body needs Dehydration Very common when appetite and thirst cues decrease Changes in routine New eating patterns can disrupt your system for a while Put it all together, and things can stall
A2: Yes, one of the unique properties of BPC-157 Peptide Therapy is its strong protective effect on the gastrointestinal lining
While semaglutide does not directly increase estrogen, the weight loss it produces can reduce excess aromatase activity and normalize estrogen ratios, particularly in women who are carrying excess visceral fat